Cytomegalovirus cavitary pneumonia in a human immunodeficiency virus‐infected patient

Authors: Yusuke Sunanaga, Takayuki Suetsugu, Yusuke Nagata, Marina Miyata, Kiyotaka Kondo, Hideo Mitsuyama, Shingo Kubota, Keiko Mizuno, Kentaro Tanaka, Hiromasa Inoue

Source: Respirology Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)

Subject Terms: acquired immunodeficiency syndrome, cavitary lung lesion, cytomegalovirus infection, human immunodeficiency virus, transbronchial biopsy, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/2051-3380

Access URL: https://doaj.org/article/62f5b30117194e47bb806c91bd61ebbc

Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets

Authors: Kengo Tanigawa, Yuya Tomioka, Shunsuke Misono, Shunichi Asai, Naoko Kikkawa, Yoko Hagihara, Takayuki Suetsugu, Hiromasa Inoue, Keiko Mizuno, Naohiko Seki

Source: FEBS Open Bio, Vol 13, Iss 9, Pp 1737-1755 (2023)

Subject Terms: lung adenocarcinoma, MCM, miR‐139‐3p, miR‐2110, miR‐378a‐5p, simurosertib, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://doaj.org/toc/2211-5463

Access URL: https://doaj.org/article/05f078ab823e43088c262c888b2bfd21

Successful Treatment with Osimertinib Based on Therapeutic Drug Monitoring in a Hemodialysis Patient with Non-Small Cell Lung Cancer: A Case Report

Authors: Keisuke Tabata, Masaya Aoki, Ryo Miyata, Tadashi Umehara, Aya Harada-Takeda, Go Kamimura, Toshiyuki Nagata, Ryuya Okizono, Hideyuki Terazono, Yasuo Takeda, Takayuki Suetsugu, Kazuhiro Ueda, Masami Sato

Source: Case Reports in Oncology, Vol 16, Iss 1, Pp 705-710 (2023)

Subject Terms: epidermal growth factor receptor mutation, osimertinib, plasma concentration, hemodialysis, case report, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://beta.karger.com/Article/FullText/531840; https://doaj.org/toc/1662-6575

Access URL: https://doaj.org/article/b5c78c72683442bba4cde407f911b044

Improving visual acuity with nivolumab plus ipilimumab plus two cycles of chemotherapy following a diagnosis of lung adenocarcinoma with choroidal metastasis: A case report and literature review

Authors: Takahiro Matsuyama, Masashi Oniwa, Kentaro Tsuruzono, Shunsuke Yasuda, Mikiko Yone, Yuya Tomioka, Akifumi Uchida, Hideo Mitsuyama, Shingo Kubota, Takayuki Suetsugu, Keiko Mizuno, Hiromasa Inoue

Source: Respirology Case Reports, Vol 12, Iss 1, Pp n/a-n/a (2024)

Subject Terms: choroidal metastasis, ipilimumab, nivolumab, non‐small cell lung cancer, vision loss, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/2051-3380

Access URL: https://doaj.org/article/b84839b5c62a42d09c3245c86a03923a

MicroRNA signature of small‐cell lung cancer after treatment failure: impact on oncogenic targets by miR‐30a‐3p control

Authors: Kengo Tanigawa, Shunsuke Misono, Keiko Mizuno, Shunichi Asai, Takayuki Suetsugu, Akifumi Uchida, Minami Kawano, Hiromasa Inoue, Naohiko Seki

Source: Molecular Oncology, Vol 17, Iss 2, Pp 328-343 (2023)

Subject Terms: downstream neighbor of SON, microRNA signature, miR‐30a‐3p, small‐cell lung cancer, treatment failure, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1574-7891; https://doaj.org/toc/1878-0261

Access URL: https://doaj.org/article/389557d4be3148dcbab70b1db4f13262

The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma

Authors: Yuya Tomioka, Takayuki Suetsugu, Naohiko Seki, Kengo Tanigawa, Yoko Hagihara, Masahiro Shinmura, Shunichi Asai, Naoko Kikkawa, Hiromasa Inoue, Keiko Mizuno

Source: Cells, Vol 12, Iss 14, p 1885 (2023)

Subject Terms: microRNA, passenger strand, miR-486-5p, miR-486-3p, GINS4, lung adenocarcinoma, Cytology, QH573-671

File Description: electronic resource

Relation: https://www.mdpi.com/2073-4409/12/14/1885; https://doaj.org/toc/2073-4409

Access URL: https://doaj.org/article/1781bf32359c4c1491d712d29086c537

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

Authors: Naoko Sueoka‐Aragane, Chiho Nakashima, Hironori Yoshida, Naohisa Matsumoto, Kentaro Iwanaga, Noriyuki Ebi, Akihiro Nishiyama, Kazuhiro Yatera, Shoichi Kuyama, Minoru Fukuda, Sunao Ushijima, Hitomi Umeguchi, Daijiro Harada, Kosuke Kashiwabara, Takayuki Suetsugu, Nobukazu Fujimoto, Fumihiro Tanaka, Hidetaka Uramoto, Chiharu Yoshii, Katsumi Nakatomi, Genju Koh, Nobuhiko Seki, Keisuke Aoe, Kaname Nosaki, Koji Inoue, Ayako Takamori, Atsushi Kawaguchi

Source: Cancer Medicine, Vol 10, Iss 12, Pp 3873-3885 (2021)

Subject Terms: molecular diagnosis, mutations, next‐generation sequencing, non‐small cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/9fdb0934bf3d40bbb7a19d2b98a77955

A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)

Authors: Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, Minoru Fukuda, Masafumi Takeshita, Takayuki Suetsugu, Keisuke Kirita, Noriyuki Ebi, Osamu Hataji, Satoru Miura, Kenji Chibana, Isamu Okamoto, Kenichi Yoshimura, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Kenji Sugio

Source: BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)

Subject Terms: Non-small cell lung cancer, EGFR T790M, CNS metastasis, Brain metastasis, Osimertinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s12885-020-06874-6; https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/c4884704459847fb8984edec803f99a8

High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib

Authors: Atsushi Osoegawa, MD, PhD, Masafumi Yamaguchi, MD, PhD, Tomomi Nakamura, MD, PhD, Ryotaro Morinaga, MD, Kentaro Tanaka, MD, PhD, Kosuke Kashiwabara, MD, PhD, Takashi Miura, MD, PhD, Takayuki Suetsugu, MD, PhD, Taishi Harada, MD, PhD, Tatsuma Asoh, MD, PhD, Kenichi Taguchi, MD, PhD, Kazuki Nabeshima, MD, PhD, Junji Kishimoto, MA, Kazuko Sakai, PhD, Kazuto Nishio, MD, PhD, Kenji Sugio, MD, PhD

Source: JTO Clinical and Research Reports, Vol 2, Iss 7, Pp 100191- (2021)

Subject Terms: Osimertinib, Targeted resequencing, Acquired resistance, EGFR T790M, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364321000503; https://doaj.org/toc/2666-3643

Access URL: https://doaj.org/article/3325e96eb81945d7a9c2b5e282c36d99

Regulation of Oncogenic Targets by Tumor-Suppressive miR-150-3p in Lung Squamous Cell Carcinoma

Authors: Keiko Mizuno, Kengo Tanigawa, Shunsuke Misono, Takayuki Suetsugu, Hiroki Sanada, Akifumi Uchida, Minami Kawano, Kentaro Machida, Shunichi Asai, Shogo Moriya, Hiromasa Inoue, Naohiko Seki

Source: Biomedicines, Vol 9, Iss 12, p 1883 (2021)

Subject Terms: microRNA, miR-150-3p, passenger strand, lung squamous cell carcinoma, HELLS, Gene Ontology, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2227-9059/9/12/1883; https://doaj.org/toc/2227-9059

Access URL: https://doaj.org/article/da15be8112484a20a188a0fdd02b5a81

FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p)

Authors: Keiko Mizuno, Kengo Tanigawa, Nijiro Nohata, Shunsuke Misono, Reona Okada, Shunichi Asai, Shogo Moriya, Takayuki Suetsugu, Hiromasa Inoue, Naohiko Seki

Source: Cells, Vol 9, Iss 9, p 2083 (2020)

Subject Terms: lung adenocarcinoma, microRNA, miR-99a-5p, miR-99a-3p, FAM64A, tumor suppressor, Cytology, QH573-671

File Description: electronic resource

Relation: https://www.mdpi.com/2073-4409/9/9/2083; https://doaj.org/toc/2073-4409

Access URL: https://doaj.org/article/53a3e75b6ffc407f954504e22991b665

Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study.

Authors: Yosuke Kakiuchi, Koichi Saruwatari, Kenta Murotani, Takaaki Tokito, Toyohisa Iriki, Jun Iwakawa, Yoshihiko Sakata, Naoki Shingu, Sho Saeki, Megumi Inaba, Akira Takaki, Shunsuke Misono, Takayuki Suetsugu, Koichi Azuma, Keiko Mizuno, Takuro Sakagami

Source: Clinical Lung Cancer; Dec2024, Vol. 25 Issue 8, p661-671, 11p

Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study.

Authors: Masaya Aoki, Ryo Miyata, Go Kamimura, Aya Harada Takeda, Takayuki Suetsugu, Keiko Mizuno, Kazuhiro Ueda

Source: Annals of Thoracic & Cardiovascular Surgery; 2024, Vol. 30 Issue 1, p1-9, 9p

This result is not displayed to guests.
Login for full access.